Amolyt Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Session. The French Market has been up 1. 3 for the week. Fresh alltime intraday high yesterday. Although there is softness on the dax, we are seeing fresh territory. As we get going this morning, we are seeing green moving on the board of the stoxx 600 and fresh alltime highs yesterday. We are looking for the levels to be breached today. Stateside, data is expected which is producer prices. The last seven, the market was questioning the theory of the deep disinflationary cycle. Just challenging the narrative on that perhaps thinking we may have sticky inflation. What we are reading the ppi pr...

The global biotechnology market was valued at approximately $1.55 trillion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 13.96% from 2024 to 2030, reaching a staggering...

Launch of 20 new medicines expected by 2030 Significant growth from existing oncology, biopharmaceuticals and rare disease portfolios Investing in disruptive innovation that will shape the future...

BioPharmaceuticals Ruud Dobber, EVP and President, BioPharmaceuticals Sharon Barr, EVP, BioPharmaceuticals R&D ...

British pharmaceutical company AstraZeneca announced on May 20 its intention to build a 1.5 billion USD facility in Singapore to produce new generation cancer treatment drugs.